{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T04:02:52Z","timestamp":1781236972874,"version":"3.54.1"},"reference-count":32,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research in Social and Administrative Pharmacy"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.sapharm.2018.07.003","type":"journal-article","created":{"date-parts":[[2018,7,3]],"date-time":"2018-07-03T14:21:08Z","timestamp":1530627668000},"page":"949-952","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Anabolic steroid users' misuse of non-traditional prescription drugs"],"prefix":"10.1016","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3997-995X","authenticated-orcid":false,"given":"Eric J.","family":"Ip","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shadi","family":"Doroudgar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bonnie","family":"Lau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitchell J.","family":"Barnett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.sapharm.2018.07.003_bib1","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1002\/j.1875-9114.2012.01123","article-title":"Psychological and physical impact of anabolic-androgenic steroid dependence","volume":"32","author":"Ip","year":"2012","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.sapharm.2018.07.003_bib2","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.mce.2017.02.039","article-title":"History and epidemiology of anabolic androgens in athletes and non-athletes","volume":"464","author":"Kanayama","year":"2018","journal-title":"Mol Cell Endocrinol"},{"issue":"5","key":"10.1016\/j.sapharm.2018.07.003_bib3","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.annepidem.2014.01.009","article-title":"The global epidemiology of anabolic-androgenic steroid use: a meta-analysis and meta-regression analysis","volume":"24","author":"Sagoe","year":"2014","journal-title":"Ann Epidemiol"},{"issue":"4","key":"10.1016\/j.sapharm.2018.07.003_bib4","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1521-0391.2013.12118.x","article-title":"The lifetime prevalence of anabolic-androgenic steroid use and dependence in Americans: current best estimates","volume":"23","author":"Pope","year":"2014","journal-title":"Am J Addict"},{"issue":"8","key":"10.1016\/j.sapharm.2018.07.003_bib5","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1592\/phco.31.8.757","article-title":"The Anabolic 500 survey: characteristics of male users versus nonusers of anabolic-androgenic steroids for strength training","volume":"31","author":"Ip","year":"2011","journal-title":"Pharmacotherapy"},{"issue":"7","key":"10.1016\/j.sapharm.2018.07.003_bib6","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1080\/10826084.2016.1267224","article-title":"Polypharmacy, infectious diseases, sexual behavior, and psychophysical health among anabolic steroid-using homosexual and heterosexual gym patrons in san Francisco's Castro District","volume":"52","author":"Ip","year":"2017","journal-title":"Subst Use Misuse"},{"key":"10.1016\/j.sapharm.2018.07.003_bib7","first-page":"12","article-title":"A league of their own: demographics, motivations and patterns of use of 1,955 male adult non-medical anabolic steroid users in the United States","volume":"4","author":"Cohen","year":"2007","journal-title":"Sports Nutr Rev J"},{"issue":"12","key":"10.1016\/j.sapharm.2018.07.003_bib8","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1111\/j.1360-0443.2009.02734.x","article-title":"Anabolic-androgenic steroid dependence: an emerging disorder","volume":"104","author":"Kanayama","year":"2009","journal-title":"Addiction"},{"issue":"4","key":"10.1016\/j.sapharm.2018.07.003_bib9","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1037\/0021-843X.116.4.717","article-title":"Modeling population heterogeneity in appearance- and performance-enhancing drug (APED) use: applications of mixture modeling in 400 regular APED users","volume":"116","author":"Hildebrandt","year":"2007","journal-title":"J Abnorm Psychol"},{"key":"10.1016\/j.sapharm.2018.07.003_bib10","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13011-015-0006-5","article-title":"Polypharmacy among anabolic-androgenic steroid users: a descriptive metasynthesis","volume":"10","author":"Sagoe","year":"2015","journal-title":"Subst Abuse Treat Prev Pol"},{"issue":"9","key":"10.1016\/j.sapharm.2018.07.003_bib11","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1111\/j.1360-0443.2004.00781.x","article-title":"Anabolic steroid users' attitudes towards physicians","volume":"99","author":"Pope","year":"2004","journal-title":"Addiction (Abingdon, England)."},{"issue":"5","key":"10.1016\/j.sapharm.2018.07.003_bib12","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1210\/jc.2018-00229","article-title":"Testosterone therapy in men with hypogonadism: an endocrine society clinical practice guideline","volume":"103","author":"Bhasin","year":"2018","journal-title":"Clin Endocrinol Metabol"},{"issue":"5","key":"10.1016\/j.sapharm.2018.07.003_bib13","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1177\/0897190014527319","article-title":"Characteristics and behaviors of older male anabolic steroid users","volume":"28","author":"Ip","year":"2015","journal-title":"J Pharm Pract"},{"key":"10.1016\/j.sapharm.2018.07.003_bib14","series-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"2013"},{"issue":"1","key":"10.1016\/j.sapharm.2018.07.003_bib15","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/(SICI)1098-108X(199907)26:1<65::AID-EAT8>3.0.CO;2-D","article-title":"Evolving ideals of male body image as seen through action toys","volume":"26","author":"Pope","year":"1999","journal-title":"Int J Eat Disord"},{"issue":"1","key":"10.1016\/j.sapharm.2018.07.003_bib16","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1001\/jama.2016.17441","article-title":"Body image disorders and abuse of anabolic-androgenic steroids among men","volume":"317","author":"Pope","year":"2017","journal-title":"Jama"},{"issue":"1","key":"10.1016\/j.sapharm.2018.07.003_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM199607043350101","article-title":"The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men","volume":"335","author":"Bhasin","year":"1996","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.sapharm.2018.07.003_bib18","doi-asserted-by":"crossref","first-page":"513","DOI":"10.2165\/00007256-200434080-00003","article-title":"Effects of androgenic-anabolic steroids in athletes","volume":"34","author":"Hartgens","year":"2004","journal-title":"Sports Med"},{"issue":"3","key":"10.1016\/j.sapharm.2018.07.003_bib19","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1210\/er.2013-1058","article-title":"Adverse health consequences of performance-enhancing drugs: an Endocrine Society scientific statement","volume":"35","author":"Pope","year":"2014","journal-title":"Endocr Rev"},{"issue":"3","key":"10.1016\/j.sapharm.2018.07.003_bib20","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/bjp.2008.165","article-title":"Pharmacology of anabolic steroids","volume":"154","author":"Kicman","year":"2008","journal-title":"Br J Pharmacol"},{"issue":"1\u20133","key":"10.1016\/j.sapharm.2018.07.003_bib21","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.drugalcdep.2010.01.011","article-title":"Treatment of anabolic-androgenic steroid dependence: emerging evidence and its implications","volume":"109","author":"Kanayama","year":"2010","journal-title":"Drug Alcohol Depend"},{"issue":"10","key":"10.1016\/j.sapharm.2018.07.003_bib22","doi-asserted-by":"crossref","first-page":"747","DOI":"10.7326\/0003-4819-148-10-200805200-00215","article-title":"Systematic review: the effects of growth hormone on athletic performance","volume":"148","author":"Liu","year":"2008","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1016\/j.sapharm.2018.07.003_bib23","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.healun.2008.01.013","article-title":"Clenbuterol increases lean muscle mass but not endurance in patients with chronic heart failure","volume":"27","author":"Kamalakkannan","year":"2008","journal-title":"J Heart Lung Transplant"},{"issue":"5","key":"10.1016\/j.sapharm.2018.07.003_bib24","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1042\/cs0830615","article-title":"Salbutamol, a beta 2-adrenoceptor agonist, increases skeletal muscle strength in young men","volume":"83","author":"Martineau","year":"1992","journal-title":"Clin. sci (London, England: 1979)"},{"issue":"10","key":"10.1016\/j.sapharm.2018.07.003_bib25","first-page":"763","article-title":"Acute poisoning with clenbuterol\u2013a case report","volume":"54","author":"Chodorowski","year":"1997","journal-title":"Przegl Lek"},{"issue":"9","key":"10.1016\/j.sapharm.2018.07.003_bib26","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1253\/circj.69.1144","article-title":"Myocardial infarction in a 17-year-old body builder using clenbuterol","volume":"69","author":"Kierzkowska","year":"2005","journal-title":"Circ J: official j. Jpn. Circ Soc"},{"issue":"4","key":"10.1016\/j.sapharm.2018.07.003_bib27","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1249\/JSR.0b013e31825da97f","article-title":"Weightlifting's risky new trend: a case series of 41 insulin users","volume":"11","author":"Ip","year":"2012","journal-title":"Curr Sports Med Rep"},{"issue":"7089","key":"10.1016\/j.sapharm.2018.07.003_bib28","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1136\/bmj.314.7089.1280","article-title":"Bodybuilders find it easy to obtain insulin to help them in training","volume":"314","author":"Elkin","year":"1997","journal-title":"BMJ (Clinical research ed)."},{"issue":"10","key":"10.1016\/j.sapharm.2018.07.003_bib29","doi-asserted-by":"crossref","first-page":"3663","DOI":"10.1210\/jc.2009-0899","article-title":"Thyroid hormone therapy for obesity and nonthyroidal illnesses: a systematic review","volume":"94","author":"Kaptein","year":"2009","journal-title":"Clin. Endocrinol. Metabol."},{"issue":"1","key":"10.1016\/j.sapharm.2018.07.003_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1039\/b201476a","article-title":"Sports drug testing\u2013an analyst's perspective","volume":"33","author":"Trout","year":"2004","journal-title":"Chem Soc Rev"},{"issue":"5","key":"10.1016\/j.sapharm.2018.07.003_bib31","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1097\/00005768-200105000-00021","article-title":"Weight loss methods of high school wrestlers","volume":"33","author":"Kiningham","year":"2001","journal-title":"Med Sci Sports Exerc"},{"issue":"1\u20133","key":"10.1016\/j.sapharm.2018.07.003_bib32","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.drugalcdep.2009.02.008","article-title":"Features of men with anabolic-androgenic steroid dependence: a comparison with nondependent AAS users and with AAS nonusers","volume":"102","author":"Kanayama","year":"2009","journal-title":"Drug Alcohol Depend"}],"container-title":["Research in Social and Administrative Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551741118302882?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551741118302882?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T09:16:45Z","timestamp":1761556605000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551741118302882"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":32,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["S1551741118302882"],"URL":"https:\/\/doi.org\/10.1016\/j.sapharm.2018.07.003","relation":{},"ISSN":["1551-7411"],"issn-type":[{"value":"1551-7411","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anabolic steroid users' misuse of non-traditional prescription drugs","name":"articletitle","label":"Article Title"},{"value":"Research in Social and Administrative Pharmacy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sapharm.2018.07.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}